Patents by Inventor Jeffrey G. Jones

Jeffrey G. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
    Patent number: 11512352
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: November 29, 2022
    Assignee: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan K. Allen, Sat Dev Batish, Hui Zhu
  • METHODS OF DETECTING MUTATIONS ASSOCIATED WITH ATAXIA-OCULAR APRAXIA 2 (AOA2)
    Publication number: 20200149107
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Application
    Filed: August 20, 2019
    Publication date: May 14, 2020
    Applicant: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan K. Allen, Sat Dev Batish, Hui Zhu
  • METHODS OF DETECTING MUTATIONS ASSOCIATED WITH ATAXIA-OCULAR APRAXIA 2 (AOA2)
    Publication number: 20170166970
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Application
    Filed: February 21, 2017
    Publication date: June 15, 2017
    Applicant: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan K. Allen, Sat Dev Batish, Hui Zhu
  • Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
    Patent number: 9611512
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: April 4, 2017
    Assignee: ATHENA DIAGNOSTICS, INC.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan K. Allen, Sat Dev Batish, Hui Zhu
  • METHODS OF DETECTING MUTATIONS ASSOCIATED WITH ATAXIA-OCULAR APRAXIA 2 (AOA2)
    Publication number: 20140323318
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Application
    Filed: July 11, 2014
    Publication date: October 30, 2014
    Inventors: Corey D. BRAASTAD, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan K. Allen, Sat Dev Batish, Hui Zhu
  • Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
    Patent number: 8785122
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: July 22, 2014
    Assignee: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan Allen, Sat Dev Batish, Hui Zhu
  • PKD mutations and evaluation of same
    Patent number: 8771946
    Abstract: The present invention relates to methods of detecting novel mutations in a PKD1 and/or PKD2 gene that have been determined to be associated with autosomal dominant polycystic kidney disease (ADPKD) in order to detect or predict the occurrence of ADPKD in an individual.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: July 8, 2014
    Assignees: Athena Diagnostics, Inc., The Johns Hopkins University
    Inventors: Terry J. Watnick, Miguel Garcia-Gonzales, Gregory G. Germino, Jeffrey G. Jones
  • METHODS OF DETECTING MUTATIONS ASSOCIATED WITH ATAXIA-OCULAR APRAXIA 2 (AOA2)
    Publication number: 20120237934
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Application
    Filed: June 4, 2012
    Publication date: September 20, 2012
    Applicant: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan Allen, Sat Dev Batish, Hui Zhu
  • Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
    Patent number: 8192933
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: June 5, 2012
    Assignee: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan Allen, Sat Dev Batish, Hui Zhu
  • Identification of a novel gene underlying familial spastic paraplegia
    Patent number: 7811762
    Abstract: Methods of identifying polymorphisms associated with hereditary spastic paraplegia (SPG), are described. The polymorphisms associated with SPG include specific mutations in the receptor expression enhancing protein 1 (REEP1) gene. Also described are methods of diagnosis of SPG.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: October 12, 2010
    Assignee: Duke University
    Inventors: Stephan Zuchner, Margaret Pericak-Vance, Allison Ashley-Koch, Corey Braastad, Narasimhan Nagan, Hui Zhu, Jeffrey G. Jones
  • Methods of Detecting Mutations Associated With Ataxia-Ocular Apraxia 2 (AOA2)
    Publication number: 20100167305
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Application
    Filed: March 11, 2010
    Publication date: July 1, 2010
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan Allen, Sat Dev Batish, Hui Zhu
  • Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
    Patent number: 7704691
    Abstract: Methods of identifying polymorphisms associated with ataxia-ocular apraxia 2 (AOA2), are described. The polymorphisms associated with AOA2 include specific mutations in the senataxin (SETX) gene. Also described are methods of diagnosis of AOA2, as well as methods of assessing an individual for carrier status for AOA2.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: April 27, 2010
    Assignee: Athena Diagnostics, Inc.
    Inventors: Corey D. Braastad, Narasimhan Nagan, Jeffrey G. Jones, William K. Seltzer, Susan Allen, Sat Dev Batish, Hui Zhu
  • Pkd mutations and evaluation of same
    Publication number: 20100047785
    Abstract: The present invention relates to methods of detecting novel mutations in a PKD1 and/or PKD2 gene that have been determined to be associated with autosomal dominant polycystic kidney disease (ADPKD) in order to detect or predict the occurrence of ADPKD in an individual.
    Type: Application
    Filed: July 24, 2007
    Publication date: February 25, 2010
    Inventors: Terry J. Watnick, Miguel Garcia-Gonzales, Gregory G. Germino, Jeffrey G. Jones
  • Compositions and methods for genetic analysis of polycystic kidney disease
    Patent number: 7521190
    Abstract: The subject invention relates to nucleic acid sequences for detection of mutations in a PKD-1 or PKD-2 gene, as well as biomarkers for ADPKD. The invention further relates to methods for diagnosing ADPKD in an individual, and kits for performing the methods of the invention. The invention also provides a method for determining in an individual the presence or absence of a mutant PKD gene.
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: April 21, 2009
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey G. Jones, Aidan N. Hennigan, John A. Curran, Susan K. Allen, Normand J. Robichaud, Jing Wang, Kerry E. Flynn, Jorge A. Garcés, Christopher M. Palatucci, William K. Seltzer
  • Compositions and methods for genetic analysis of polycystic kidney disease
    Patent number: 7273701
    Abstract: The subject invention relates to nucleic acid sequences for detection of mutations in a PKD-1 or PKD-2 gene, as well as biomarkers for ADPKD. The invention further relates to methods for diagnosing ADPKD in an individual, and kits for performing the methods of the invention. The invention also provides a method for determining in an individual the presence or absence of a mutant PKD gene.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: September 25, 2007
    Assignee: Athena Diagnostics, Inc.
    Inventors: Jeffrey G. Jones, Aidan N. Hennigan, John A. Curran, Susan K. Allen, Normand J. Robichaud, Jing Wang, Kerry E. Flynn, Jorge A. Garcés, Christopher M. Palatucci, William K. Seltzer
  • Forward looking infrastructure re-provisioning
    Publication number: 20040153563
    Abstract: The present invention provides systems and methods for predicting expected service levels based on measurements relating to network traffic data. Measured network performance characteristics can be converted to metrics for quantifying network performance. The response time metric may be described as a service level metric whereas bandwidth, latency, utilization and processing delays may be classified as component metrics of the service level metric. Service level metrics have certain entity relationships with their component metrics that may be exploited to provide a predictive capability for service levels and performance. The present invention involves system and methods for processing metrics representing current conditions in a network, in order to predict future values of those metrics.
    Type: Application
    Filed: March 31, 2003
    Publication date: August 5, 2004
    Inventors: A. David Shay, Michael S. Percy, Jeffrey G. Jones
  • Universal dialyzer cap
    Patent number: D565728
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: April 1, 2008
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventor: Jeffrey G. Jones